The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Or the fact that there is no appetite to buy and the MMs need to create a market to make money and there are those willing to sell at this level. Not sure what game there is.
Could someone advise on how long the phase 3 will take to complete? Including time for data to be analysed and results published
The last Phase 3 trial took approximately 2 years, from sites opening in the US for recruitment of patients in Dec '15 , first dosing in Feb '16, and the last dosing completed in Dec '17. This was a 52-week, randomised, double-blinded, Phase III clinical trial of 200 patients. Results were released end Q1 2018, with regular updates along the way.
With Avion involved this time around, expect the commencement to be sooner than the timeline previously due to fund raises.
"As previously advised, we expect study results to be available around the end of Q1 2022." Not exactly a promise, but also it's still "around" the end of the Q. I would imagine the results have to go to the FDA before being released publicly.
Be interesting to know how long they expect the trial to take? Or perhaps I've missed something there.
Is that right? FAB holding seems to be unchanged, only the percentage has changed, so no shares have been sold. I could be wrong, but that's what the Holding RNS suggests.
The update RNS of 10/09 stated "Gallium Maltolate phase I clinical trial will now commence towards the end of Q4 2021" so we should get some news before year end.
The Mayo Clinic, LA County Hospital, Keck Medical Centre, Montgomery Cancer Centre, St Jude's Children's Hospital. To name just a few.
Nope, just fed up with people pretending they know more than others. Everybody can see it going down, Questions are asked, but scaremongering about Avion pulling out is BS. Possibly placing, true, but bust? Doubt it. I love the fact that people come on boards and say "told you so" as though they have some financial insight. Currently there are better short term gains to be made after the market wide drop over the last few days. Just as much a valid reason as any other as to why it's down. People trading.
Ignore the noise. Rumours of Avion pulling out started by ALB1. Board of Directors gone AWOL - within the last two weeks we've had an RNS that contradicts this. Michael2021 states he's got " all my money here, stupid me." yet his post history confirms otherwise. Ignore the noise..
Definitely scaremongering, but also definitely something going on. Could be forward selling prior to a placing, but equally could be MMs walking this down to fill a large buy order.
Yep, two new contracts RNS this month already.
placing shares.
I'm not sure 10p on the PK study. Unfortunately, the PK study came out of the blue for most of us and is a delay to the Phase 3 trial. Hopefully it's just a formality. RNS advised that the PK study will take between 8-12 weeks to complete, from commencement. "ImmuPharma will provide an update on the progress of the PK study once it has commenced." so we must assume it hasn't yet commenced. Above 10p on the commencement of Phase 3 no doubt IMO.
Now that IQAI is listed on a US market, this RNS might be the catalyst and cross the radar of those not yet aware of IQAI or waiting on side lines in US. When does the market open over there?
investegate
plus he's not likely to reply via this forum.
What time does this market open up? 2.30pm (UK time?). I would think US brokers will have been pushing this from the get go, and without any sells in US possible today, we should see a flurry of buys this afternoon, pushing the SP up.
Something else to consider when placing a figure on the value of annual sales, is that Benlysta is the sole drug for Lupus at the moment and Glaxo can therefore charge what they like. The only way in for the competition, other than with a far superior drug, is to undercut, but then Glaxo will probably also reduce costs, so the overall value of the market reduces.
We haven't had an update since February, and the start of the Phase 3 study was scheduled for H2 2021, so any day now?